Eltrombopag for Inherited Thrombocytopenias

Trial Profile

Eltrombopag for Inherited Thrombocytopenias

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 21 Feb 2018

At a glance

  • Drugs Eltrombopag (Primary)
  • Indications Congenital disorders; Platelet dysfunction
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Aug 2017 Planned primary completion date changed from 1 May 2017 to 1 Sep 2017.
    • 28 Feb 2017 Status changed from recruiting to active, no longer recruiting.
    • 28 Apr 2015 Status changed from not yet recruiting to recruiting as reported by Clinical Trials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top